Total Payments
$6,100
2024 Payments
$819.27
Companies
42
Transactions
149
Medicare Patients
5,782
Medicare Billing
$516,017
Payment Breakdown by Category
Food & Beverage$4,986 (81.7%)
Travel$922.99 (15.1%)
Education$190.49 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,986 | 142 | 81.7% |
| Travel and Lodging | $922.99 | 4 | 15.1% |
| Education | $190.49 | 3 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,483 | 22 | $0 (2022) |
| Astellas Pharma US Inc | $537.32 | 21 | $0 (2024) |
| Medtronic, Inc. | $334.64 | 11 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $246.62 | 9 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $241.91 | 6 | $0 (2024) |
| KARL STORZ Endoscopy-America | $153.49 | 2 | $0 (2019) |
| ABBVIE INC. | $134.06 | 7 | $0 (2024) |
| GENZYME CORPORATION | $121.78 | 1 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $119.67 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $112.56 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $819.27 | 27 | Dendreon Pharmaceuticals LLC ($194.55) |
| 2023 | $626.83 | 28 | Medtronic, Inc. ($144.93) |
| 2022 | $982.09 | 21 | Boston Scientific Corporation ($509.78) |
| 2021 | $833.14 | 26 | BOSTON SCIENTIFIC CORPORATION ($239.67) |
| 2020 | $293.52 | 11 | Astellas Pharma US Inc ($156.87) |
| 2019 | $686.05 | 15 | Boston Scientific Corporation ($234.00) |
| 2018 | $1,350 | 12 | BOSTON SCIENTIFIC CORPORATION ($1,194) |
| 2017 | $509.27 | 9 | BOSTON SCIENTIFIC CORPORATION ($305.30) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/15/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: HORMONE THERAPY | ||||||
| 11/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/13/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $23.05 | General |
| 10/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $118.30 | General |
| Category: Oncology | ||||||
| 08/12/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $136.95 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/12/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: HORMONE THERAPY | ||||||
| 06/29/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: Oncology | ||||||
| 05/18/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Diagnostic Imaging | ||||||
| 04/12/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: Prostate cancer | ||||||
| 03/22/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $22.55 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/01/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: HORMONE THERAPY | ||||||
| 02/29/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $94.38 | General |
| Category: Urology | ||||||
| 02/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 02/09/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 02/02/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Oncology | ||||||
| 02/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,513 | 2,090 | $372,009 | $125,738 |
| 2022 | 24 | 1,396 | 1,997 | $393,572 | $129,755 |
| 2021 | 28 | 1,523 | 2,183 | $443,822 | $145,413 |
| 2020 | 25 | 1,350 | 1,907 | $355,325 | $115,111 |
Total Patients
5,782
Total Services
8,177
Medicare Billing
$516,017
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 331 | 434 | $49,910 | $25,561 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 203 | $35,322 | $17,647 | 50.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 15 | 122 | $51,240 | $16,517 | 32.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 84 | 96 | $43,584 | $13,684 | 31.4% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 28 | 28 | $25,368 | $7,109 | 28.0% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 12 | 12 | $25,056 | $6,840 | 27.3% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 17 | 17 | $22,626 | $5,638 | 24.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 19 | 21 | $13,839 | $5,143 | 37.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 45 | $14,490 | $4,617 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $8,928 | $4,220 | 47.3% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 24 | 24 | $8,832 | $3,494 | 39.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $5,610 | $2,067 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $3,276 | $1,845 | 56.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 15 | 15 | $3,975 | $1,552 | 39.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 15 | 19 | $7,858 | $1,534 | 19.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 432 | 675 | $8,100 | $1,481 | 18.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 29 | $2,552 | $1,139 | 44.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 16 | $3,656 | $1,050 | 28.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 29 | $2,175 | $958.98 | 44.1% |
| 52352 | Removal or manipulation of stone in ureter or kidney using an endoscope | Facility | 2023 | 11 | 11 | $10,593 | $914.51 | 8.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 28 | $2,800 | $716.24 | 25.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 45 | $1,845 | $703.20 | 38.1% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 25 | 25 | $11,850 | $618.50 | 5.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 66 | 76 | $3,572 | $534.66 | 15.0% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 24 | 24 | $4,920 | $129.39 | 2.6% |
About Patrick Irwin
Patrick Irwin is a Urology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1326481128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Irwin has received a total of $6,100 in payments from pharmaceutical and medical device companies, with $819.27 received in 2024. These payments were reported across 149 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,986).
As a Medicare-enrolled provider, Irwin has provided services to 5,782 Medicare beneficiaries, totaling 8,177 services with total Medicare billing of $516,017. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Cleveland, OH
- Active Since 04/10/2013
- Last Updated 01/03/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1326481128
Products in Payments
- AMS (Device) $1,484
- INTERSTIM (Device) $444.33
- XTANDI (Drug) $303.00
- PROVENGE (Drug) $241.91
- ORGOVYX (Drug) $189.04
- LITHOCLAST (Device) $174.90
- SpaceOAR VUE System - 10mL (Device) $173.79
- Flexiva (Device) $161.09
- Nubeqa (Drug) $128.32
- JEVTANA (Drug) $121.78
- LITHOVUE (Device) $120.04
- TRIA (Device) $119.63
- Xofigo (Drug) $118.30
- ADVANCE (Device) $112.92
- ERLEADA (Drug) $112.56
- Axonics (Device) $108.56
- FIRMAGON (Drug) $101.11
- LUPRON DEPOT (Drug) $98.26
- MYRBETRIQ (Drug) $95.60
- CUTTING LOOP, BIPOLAR, 0.30MM, 24/26 FR. (Device) $95.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Cleveland
Howard Goldman, Md, MD
Urology — Payments: $688,743
Urology $688,743
Jihad Kaouk, Md, MD
Urology — Payments: $258,551
Urology $258,551
Sandip Vasavada, Md, MD
Urology — Payments: $247,878
Urology $247,878
Petar Bajic, M.d, M.D
Urology — Payments: $238,227
Urology $238,227
Dr. Sriharan Sivalingam, Md, MD
Urology — Payments: $210,140
Urology $210,140
Ruben Olivares, Md, MD
Urology — Payments: $174,034
Urology $174,034